Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction
NCT ID: NCT05012982
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2023-02-16
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation
NCT04635579
Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction
NCT04484961
The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial
NCT05754632
Use of Blood Flow Restriction Therapy Following ACL Tear
NCT04374968
Blood Flow Restriction Training (BFR) in an Adolescent Population
NCT04285879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The AirBands will be placed at each of the two training sessions and inflated while an ultrasound probe is placed over the femoral artery. The cuff will be inflated until the artery reaches 60% occlusion. The force will be applied using a wireless Bluetooth signal; participants will not be asked to adjust the device. Participants will be observed by a certified Personal Therapist throughout the training session in order to determine compliance and ensure safety as is standard protocol for a physical therapy session.
The study team hypothesizes that the BFR will:
* Promote an anabolic immunometabolic signature, reflected in the composition of serum amino acid concentrations and anabolic hormone content
* Enhance anaerobic glycolysis in leukocytes (which has been associated with increased activation in other settings (Marelli-Berg and Jangani, 2018; Pearce and Pearce, 2013))
* Increase leukocyte glucose and pyruvate concentrations, which corresponds to acute energy provision to promote repair
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AirBand followed by uninflated AirBand
The order of study days will be randomized. participants will wear an uninflated AirBand as the control intervention during the session in which BFR is not performed,
AirBand
The AirBands will be placed at each of the two training sessions and inflated while an ultrasound probe is placed over the femoral artery. The cuff will be inflated until the artery reaches 60% occlusion. The force will be applied using a wireless Bluetooth signal; participants will not be asked to adjust the device. Participants will be observed by a certified Personal Therapist throughout the training session in order to determine compliance and ensure safety as is standard protocol for a physical therapy session.
uninflated AirBand
Uninflated AirBand will be used as the control intervention during the session in which BFR is not performed
Uninflated Airbnd followed by AirBand
The order of study days will be randomized. participants will wear an uninflated AirBand as the control intervention during the session in which BFR is not performed,
AirBand
The AirBands will be placed at each of the two training sessions and inflated while an ultrasound probe is placed over the femoral artery. The cuff will be inflated until the artery reaches 60% occlusion. The force will be applied using a wireless Bluetooth signal; participants will not be asked to adjust the device. Participants will be observed by a certified Personal Therapist throughout the training session in order to determine compliance and ensure safety as is standard protocol for a physical therapy session.
uninflated AirBand
Uninflated AirBand will be used as the control intervention during the session in which BFR is not performed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AirBand
The AirBands will be placed at each of the two training sessions and inflated while an ultrasound probe is placed over the femoral artery. The cuff will be inflated until the artery reaches 60% occlusion. The force will be applied using a wireless Bluetooth signal; participants will not be asked to adjust the device. Participants will be observed by a certified Personal Therapist throughout the training session in order to determine compliance and ensure safety as is standard protocol for a physical therapy session.
uninflated AirBand
Uninflated AirBand will be used as the control intervention during the session in which BFR is not performed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Stated willingness to comply with all study procedures and availability for two study visits at least 1 week apart
3. All genders, between 18 and 60 years of age
4. In good general health without any underlying medical conditions or prior injury that would place the subject at risk of further injury/illness by participating in the study
Exclusion Criteria
2. Multiple ligament ruptures or trauma
3. Rheumatoid arthritis or other significant comorbidities
4. Lower extremity vascular pathology, including history of deep vein thrombosis
5. Those with a history of sickle cell trait or disease
6. Use of anticoagulant medications
7. Pregnancy
8. Treatment with another investigational drug or other intervention within one month of Study Day 1
9. Current smoker or tobacco use within 3 months of Study Day 1
10. Febrile illness within 2 weeks of Study Day 1
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rachel Perry, PhD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale New Haven Hospital
Milford, Connecticut, United States
Gaylord Outpatient Physical Therapy North Haven Clinic
North Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000030152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.